Karen Dodge - Concepedia

Author

Karen Dodge

Also Known As

K Dodge, K. L. Dodge, Karen Dodge

Publications

489

Citations

H-Index

Concepts

All Affiliations

Karen Dodge is an author at Trillium Therapeutics (Canada) specializing in medicine, cardiovascular physiology, and cell biology.

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	194
2	Cell Biology	2	2	71
3	Immunology	2	2	71
4	Metabolism	2	2	123
5	Biochemistry	1	1	21

Karen Dodge

Publications

463

Citations

H-Index

Page 1

	Year	Citations
TTI-621 (SIRPαFc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding Penka S. Petrova, Natasja Nielsen Viller, Mark Wong, Clinical Cancer Research	2016	269
Peroxynitrite impairs cardiac contractile function by decreasing cardiac efficiency Richard Schulz, Karen Dodge, Gary D. Lopaschuk, American Journal of Physiology-Heart and Circulatory Physiology Cardiac MuscleHeart FailureMedicineRat HeartsPhysiology	1997	102
TTI-621 (SIRPαFc), a CD47-blocking cancer immunotherapeutic, triggers phagocytosis of lymphoma cells by multiple polarized macrophage subsets Gloria H. Y. Lin, Vien Chai, Vivian Lee, PLoS ONE Tumor-associated MacrophagesImmune RegulationImmunologyImmunoeditingImmunologic Mechanism	2017	59
Pyruvate Augments Mechanical Function via Activation of the Pyruvate Dehydrogenase Complex in Reperfused Ischemic Immature Rabbit Hearts Yoshikatsu Saiki, Gary D. Lopaschuk, Karen Dodge, Journal of Surgical Research MechanobiologyCardiac MuscleCardiomyopathyHeart FailureBiochemistry	1998	21
Abstract 2709: TTI-622 (SIRPα-IgG4 Fc), a CD47-blocking innate immune checkpoint inhibitor, suppresses tumor growth and demonstrates enhanced efficacy in combination with antitumor antibodies in both hematologic and solid tumor models Gloria H. Y. Lin, Natasja Nielsen Viller, Marilyse Chabonneau, Cancer Research ImmunologyImmune RegulationCell DeathImmunoeditingImmunologic Mechanism	2018	12

Page 1